http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110621654-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate | 2018-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110621654-B |
| titleOfInvention | TRPV1 Modulator Compounds |
| abstract | The present invention relates to a TRPV1 modulator compound of formula (I) or a pharmaceutically, veterinary or cosmetically acceptable salt thereof, or a stereoisomer or a mixture thereof, wherein m is an integer selected from 1 to 3; R 1 , R 2 , R 6 and R 6′ are independently selected from H, (C 1 -C 8 )alkyl, unsaturated (C 2 -C 8 )hydrocarbon and (C 3 -C 6 )cycloalkyl, these groups Optionally have a substituent; R 3 is hydrogen or halogen; R 4 is selected from H, (C 1 -C 8 ) alkyl, unsaturated (C 2 -C 8 ) hydrocarbon, (C 3 -C 6 ) cycloalkane group, (C 6 -C 12 ) aryl and (C 5 -C 12 ) heteroaryl, these groups optionally have substituents; and R 5 is selected from (C 3 -C 28 ) alkyl, unsaturated (C 3 -C 28 ) hydrocarbons, (C 6 -C 12 ) aryl groups and (C 5 -C 12 ) heteroaryl groups, these groups optionally have substituents. The present invention also relates to methods for the preparation of said compounds; pharmaceutical, veterinary or cosmetic compositions containing said compounds; and pharmaceutical, veterinary and cosmetic applications thereof. |
| priorityDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 271.